Kiyoko Kataoka

Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)

Yutaka Kokubo, Akihiko Gemma, Rintaro Noro et al. · British Journal of Cancer · 2005 · 135 citations · Full text

Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model

Akihiko Miyanaga, Akihiko Gemma, Rintaro Noro et al. · Molecular Cancer Therapeutics · 2008 · 95 citations

Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation

Rintaro Noro, Akihiko Gemma, Seiji Kosaihira et al. · BMC Cancer · 2006 · 66 citations · Full text

PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors

Shoji Kudoh, Akinobu Yoshimura, Kiyoko Kataoka et al. · International Journal of Oncology · 2007 · 53 citations · Full text

Epigenetics, Tumor Biology, Receptor Tyrosine Kinase +16

Histone deacetylase inhibitor enhances sensitivity of non‐small‐cell lung cancer cells to 5‐FU/S‐1 via down‐regulation of thymidylate synthase expression and up‐regulation of p21^waf1/cip1 expression

Rintaro Noro, Akihiko Miyanaga, Yuji Minegishi et al. · Cancer Science · 2010 · 41 citations · Full text

Histone Deacetylase Inhibitor, Several Histone, Cancer Biology +20